

The Latest Updates in Longevity Research with Dr. Eric Verdin
43 snips Dec 13, 2023
Dr. Eric Verdin, CEO of The Buck Institute, discusses the latest updates in longevity research including the future of anti-aging drugs, the question of whether aging is a disease, and the potential for a maximum lifespan. He also shares insights on senescence and senolytics, the impact of genetics and lifestyle on longevity, and the importance of optimizing lifestyle factors for a longer and healthier lifespan.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Introduction
00:00 • 2min
Revolutionizing Aging Research: The Buck Institute's Contributions
02:10 • 6min
Biomarkers of Aging and Epigenetic Clocks
07:45 • 7min
Funding, Public Opinion, and Potential Drugs for Aging Research
14:30 • 10min
Senescence: Cellular Aging and Inflammation
24:57 • 7min
Personalized Medicine in Longevity Research
32:26 • 4min
Side Effects of GLP-1 Drugs and Progress in Longevity Research
36:02 • 5min
Genetics, Lifestyle, and Longevity
41:17 • 25min